Kurowska et al. [24] discussed the role of ACPA in the early phases of RA indicating that the presence of ACPA is highly associated with the activation of synovial fibroblasts, which upregulate CAMs and secrete proinflammatory cytokines in RA patients. The gene discussed is PRTN3; the disease is rheumatoid arthritis.